Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2019 PRIZE WINNERS

2019 Prize Winners

News

May 21, 2019
PRESS RELEASE: PERSHING SQUARE SOHN PRIZE AWARDS $4.2M TO SEVEN “NEXT GENERATION” INNOVATORS IN CANCER RESEARCH

Business Wire — The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to talented New York City-area cancer research scientists and physician-scientists.  The Prize, totaling $4.2 million in funding awarded, emboldens early-career investigators to pursue research projects at a stage when traditional funding is lacking. Recipients receive $200,000 per year for up to three years.  The awards will be presented on May 22, 2019.

READ MORE

Events

May 22, 2019 
SIXTH ANNUAL PERSHING SQUARE SOHN PRIZE DINNER

On Wednesday, May 22nd, the Pershing Square Sohn Cancer Research Alliance held its Sixth Annual Prize Dinner at the Consulate General of France in New York, awarding its 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research to seven early-career pioneers in cancer research in New York City.The evening began with remarks by Consul General Anne-Claire Legendre followed by Olivia Tournay Flatto, PhD, President of The Pershing Square Foundation and Co-founder and Executive Director of the Pershing Square Sohn Cancer Research Alliance. After introductory remarks, Stephanie Oestreich, PhD, Executive Vice President of Evotec and member of the Kendall Square Orchestra, performed a beautiful violin solo. After the entrée, three current Pershing Square Sohn Prize winners were interviewed by The Pershing Square Foundation Co-Trustee and founder, William Ackman.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation